Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens

Mauro Bombaci, Renata Grifantini, Marirosa Mora, Valerio Reguzzi, Roberto Petracca, Eva Meoni, Sergio Balloni, Chiara Zingaretti, Fabiana Falugi, Andrea G O Manetti, Immaculada Margarit, James M Musser, Francesco Cardona, Graziella Orefici, Guido Grandi, Giuliano Bensi, Mauro Bombaci, Renata Grifantini, Marirosa Mora, Valerio Reguzzi, Roberto Petracca, Eva Meoni, Sergio Balloni, Chiara Zingaretti, Fabiana Falugi, Andrea G O Manetti, Immaculada Margarit, James M Musser, Francesco Cardona, Graziella Orefici, Guido Grandi, Giuliano Bensi

Abstract

The human pathogen Group A Streptococcus (Streptococcus pyogenes, GAS) is widely recognized as a major cause of common pharyngitis as well as of severe invasive diseases and non-suppurative sequelae associated with the existence of GAS antigens eliciting host autoantibodies. It has been proposed that a subset of paediatric disorders characterized by tics and obsessive-compulsive symptoms would exacerbate in association with relapses of GAS-associated pharyngitis. This hypothesis is however still controversial. In the attempt to shed light on the contribution of GAS infections to the onset of neuropsychiatric or behavioral disorders affecting as many as 3% of children and adolescents, we tested the antibody response of tic patient sera to a representative panel of GAS antigens. In particular, 102 recombinant proteins were spotted on nitrocellulose-coated glass slides and probed against 61 sera collected from young patients with typical tic neuropsychiatric symptoms but with no overt GAS infection. Sera from 35 children with neither tic disorder nor overt GAS infection were also analyzed. The protein recognition patterns of these two sera groups were compared with those obtained using 239 sera from children with GAS-associated pharyngitis. This comparative analysis identified 25 antigens recognized by sera of the three patient groups and 21 antigens recognized by tic and pharyngitis sera, but poorly or not recognized by sera from children without tic. Interestingly, these antigens appeared to be, in quantitative terms, more immunogenic in tic than in pharyngitis patients. Additionally, a third group of antigens appeared to be preferentially and specifically recognized by tic sera. These findings provide the first evidence that tic patient sera exhibit immunological profiles typical of individuals who elicited a broad, specific and strong immune response against GAS. This may be relevant in the context of one of the hypothesis proposing that GAS antigen-dependent induction of autoantibodies in susceptible individuals may be involved the occurrence of tic disorders.

Conflict of interest statement

Competing Interests: M.M, V.R., R.P., F.F., A.M., I.M., G.G. and G.B. are employed by the Company that funded the work. G.G. and I.M. are holders of company stock options. All other authors report no potential conflicts.

Figures

Figure 1. Protein micro array set-up and…
Figure 1. Protein micro array set-up and validation.
A, SDS-PAGE analysis of purified recombinant GAS proteins stained with Coomassie. Molecular weight markers in lane 1. B, Representative image of a chip after incubation with a human serum and with Cy3-labelled anti-human IgG and Cy5-labelled anti-human IgM. Replicates of tested antigens and of negative and positive IgG and IgM controls are highlighted. C, graphic representation of the control human IgG curve. Orange dots correspond to the different IgG concentrations measured on the x-axis, while the continuous line corresponds to the interpolated resulting curve. MFIs values are reported on the y-axis. The chip image of different IgG concentration revealed by incubation with anti-human IgG-Cy3 is shown below the graph. D, Sigmoid-derived data normalization method. Data are normalized using the sigmoid control curve (black) referred to a reference sigmoid curve (red). IgG control concentrations and MFIs are reported on the x- and the y-axis respectively. HL, high level signal area (normalized MFI value >40,000); LL, low level signal area (normalized MFI value

Figure 2. Tic, No Tic and Pharyngitis…

Figure 2. Tic, No Tic and Pharyngitis sera analysis.

A, Unsupervised hierarchical clustering of human…

Figure 2. Tic, No Tic and Pharyngitis sera analysis.
A, Unsupervised hierarchical clustering of human Tic (n = 61), No Tic (n = 35) and Pharyngitis (n = 239) sera versus the 102 selected GAS antigens. Antigens/sera interactions resulting in signals with high or low FI are visualized in yellow and blue respectively. Color scale of signal intensity is reported on top-left. Clusters group antigens and/or sera showing similar reactivity profiles. Bars and roman numbers on the right of the dendrogram identify the sera clusters considered for the analysis. Light green lines next to cluster bars highlight how the 61 tic sera distribute within the dendrogram. Colored bars at the bottom of the dendrogram highlight the distribution of group 1, group 2 and group 3 antigens, as defined in Tables I, II and III. B, Distribution of sera in the different clusters. The histogram shows the percent of positive sera (FI>15,000) for each class in relation to the five defined clusters. The number of positive sera in each cluster calculated on the total number of sera tested for each group is shown in the table below the histogram.

Figure 3. Correlation between sera ELISA titers…

Figure 3. Correlation between sera ELISA titers and MFI.

Black circles and triangles represent the…

Figure 3. Correlation between sera ELISA titers and MFI.
Black circles and triangles represent the ELISA Titers (geometric means, x-axis) and Mean Fluorescent Intensities (arithmetic means, y-axis) obtained using 8 sera from either no tic or tic patients with each of the antigens Spy0843, M5005_Spy0249, Spy1306 and Spy1939. Standard errors of the means are reported. Both ELISA titers and MFIs differences between the two sera classes were statistically significant with P values

Figure 4. Relative reactivity of the three…

Figure 4. Relative reactivity of the three sera classes.

A, Percentages of tested GAS antigens…

Figure 4. Relative reactivity of the three sera classes.
A, Percentages of tested GAS antigens recognized by at least 30% of sera for each patient group. B, Percentages of antigens recognized by at least 30% of the sera of each class with FI>40,000. C, Percentages of sera for each class reacting with at least 30% of the antigens and with FI>40,000. Numbers above histograms bars indicate P values calculated with the two-tailed χ2 test.
Similar articles
Cited by
References
    1. Cunningham MW. Pathogenesis of Group A Streptococcal Infections. Clin Microbiol Rev. 2000;13:470–511. - PMC - PubMed
    1. Cunningham MW. Pathogenesis of group A streptococcal infections and their sequelae. Adv Exp Med Biol. 2008;609:29–42. - PubMed
    1. Martino D, Giovannoni G. Autoaggressive immune-mediated movement disorders. Adv Neurol. 2005;96:320–335. - PubMed
    1. Weiner SG, Normandin PA. Sydenham chorea: a case report and review of the literature. Pediatr Emerg Care. 2007;23:20–24. - PubMed
    1. Dale RC, Church AJ, Cardoso F, Goddard E, Cox TC, et al. Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Annals of Neurology. 2001;50:588–595. - PubMed
Show all 31 references
Publication types
MeSH terms
Substances
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 2. Tic, No Tic and Pharyngitis…
Figure 2. Tic, No Tic and Pharyngitis sera analysis.
A, Unsupervised hierarchical clustering of human Tic (n = 61), No Tic (n = 35) and Pharyngitis (n = 239) sera versus the 102 selected GAS antigens. Antigens/sera interactions resulting in signals with high or low FI are visualized in yellow and blue respectively. Color scale of signal intensity is reported on top-left. Clusters group antigens and/or sera showing similar reactivity profiles. Bars and roman numbers on the right of the dendrogram identify the sera clusters considered for the analysis. Light green lines next to cluster bars highlight how the 61 tic sera distribute within the dendrogram. Colored bars at the bottom of the dendrogram highlight the distribution of group 1, group 2 and group 3 antigens, as defined in Tables I, II and III. B, Distribution of sera in the different clusters. The histogram shows the percent of positive sera (FI>15,000) for each class in relation to the five defined clusters. The number of positive sera in each cluster calculated on the total number of sera tested for each group is shown in the table below the histogram.
Figure 3. Correlation between sera ELISA titers…
Figure 3. Correlation between sera ELISA titers and MFI.
Black circles and triangles represent the ELISA Titers (geometric means, x-axis) and Mean Fluorescent Intensities (arithmetic means, y-axis) obtained using 8 sera from either no tic or tic patients with each of the antigens Spy0843, M5005_Spy0249, Spy1306 and Spy1939. Standard errors of the means are reported. Both ELISA titers and MFIs differences between the two sera classes were statistically significant with P values

Figure 4. Relative reactivity of the three…

Figure 4. Relative reactivity of the three sera classes.

A, Percentages of tested GAS antigens…

Figure 4. Relative reactivity of the three sera classes.
A, Percentages of tested GAS antigens recognized by at least 30% of sera for each patient group. B, Percentages of antigens recognized by at least 30% of the sera of each class with FI>40,000. C, Percentages of sera for each class reacting with at least 30% of the antigens and with FI>40,000. Numbers above histograms bars indicate P values calculated with the two-tailed χ2 test.
Figure 4. Relative reactivity of the three…
Figure 4. Relative reactivity of the three sera classes.
A, Percentages of tested GAS antigens recognized by at least 30% of sera for each patient group. B, Percentages of antigens recognized by at least 30% of the sera of each class with FI>40,000. C, Percentages of sera for each class reacting with at least 30% of the antigens and with FI>40,000. Numbers above histograms bars indicate P values calculated with the two-tailed χ2 test.

References

    1. Cunningham MW. Pathogenesis of Group A Streptococcal Infections. Clin Microbiol Rev. 2000;13:470–511.
    1. Cunningham MW. Pathogenesis of group A streptococcal infections and their sequelae. Adv Exp Med Biol. 2008;609:29–42.
    1. Martino D, Giovannoni G. Autoaggressive immune-mediated movement disorders. Adv Neurol. 2005;96:320–335.
    1. Weiner SG, Normandin PA. Sydenham chorea: a case report and review of the literature. Pediatr Emerg Care. 2007;23:20–24.
    1. Dale RC, Church AJ, Cardoso F, Goddard E, Cox TC, et al. Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Annals of Neurology. 2001;50:588–595.
    1. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, et al. Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections: Clinical Description of the First 50 Cases. Am J Psychiatry. 1998;155:264–271.
    1. Luo F, Leckman JF, Katsovich L, Findley D, Grantz H, et al. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics. 2004;113:e578–585.
    1. Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med. 2002;156:356–361.
    1. Kurlan R, Johnson D, Kaplan EL, and the Tourette Syndrome Study G. Streptococcal Infection and Exacerbations of Childhood Tics and Obsessive-Compulsive Symptoms: A Prospective Blinded Cohort Study. Pediatrics. 2008;121:1188–1197.
    1. Leckman JF, Bloch MH, King RA, Scahill L. Phenomenology of tics and natural history of tic disorders. Adv Neurol. 2006;99:1–16.
    1. Zhu H, Snyder M. Protein chip technology. Current Opinion in Chemical Biology. 2003;7:55–63.
    1. Martin JM, Green M, Barbadora KA, Wald ER. Group A Streptococci Among School-Aged Children: Clinical Characteristics and the Carrier State. Pediatrics. 2004;114:1212–1219.
    1. Cardona F, Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr. 2001;138:71–75.
    1. Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med. 2002;8:295–301.
    1. Garvey MA, Giedd J, Swedo SE. PANDAS: the search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever. J Child Neurol. 1998;13:413–423.
    1. Dale RC. Post-streptococcal autoimmune disorders of the central nervous system. Dev Med Child Neurol. 2005;47:785–791.
    1. Lougee L, Perlmutter SJ, Nicolson R, Garvey MA, Swedo SE. Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). J Am Acad Child Adolesc Psychiatry. 2000;39:1120–1126.
    1. Cunningham MW. T cell mimicry in inflammatory heart disease. Molecular Immunology. 2004;40:1121–1127.
    1. Guilherme L, Fae KC, Oshiro SE, Tanaka AC, Pomerantzeff PM, et al. T cell response in rheumatic fever: crossreactivity between streptococcal M protein peptides and heart tissue proteins. Curr Protein Pept Sci. 2007;8:39–44.
    1. Fontan PA, Pancholi V, Nociari MM, Fischetti VA. Antibodies to Streptococcal Surface Enolase React with Human a-Enolase: Implications in Poststreptococcal Sequelae. The Journal of Infectious Diseases. 2000;182:1712–1721.
    1. Martins TB, Hoffman JL, Augustine NH, Phansalkar AR, Fischetti VA, et al. Comprehensive analysis of antibody responses to streptococcal and tissue antigens in patients with acute rheumatic fever. Int Immunol. 2008;20:445–452.
    1. Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson M. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry. 2003;74:602–607.
    1. Dale RC, Heyman I, Giovannoni G, Church AWJ. Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. The British Journal of Psychiatry. 2005;187:314–319.
    1. Müller N, Kroll B, Schwarz MJ, Riedel M, Straube A, et al. Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome. Psychiatry Res. 2001;101:187–193.
    1. Bronze MS, Dale JB. Epitopes of streptococcal M proteins that evoke antibodies that cross- react with human brain. J Immunol. 1993;151:2820–2828.
    1. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9:914–920.
    1. Kansy JW, Katsovich L, McIver KS, Pick J, Zabriskie JB, et al. Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol. 2006;181:165–176.
    1. Dale RC, Candler PM, Church AJ, Wait R, Pocock JM, et al. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol. 2006;172:187–197.
    1. Harris K, Singer HS. Tic disorders: neural circuits, neurochemistry, and neuroimmunology. J Child Neurol. 2006;21:678–689.
    1. Montigiani S, Falugi F, Scarselli M, Finco O, Petracca R, et al. Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun. 2002;70:368–379.
    1. Harris JW, Stocker H. Maximum Likelihood Method. Handbook of Mathematics and Computational Science. 1998;1:824.

Source: PubMed

3
Abonnere